Back to Markets
CAPerspective Therapeutics Inc

Perspective Therapeutics Inc

CATXNYSE MKT LLC
Health CareBiotechnology

$3.94

-0.110000 (-2.72%)

As of 05/29/26 EDT · USD

Compare
Low: $1.96Current: $3.94High: $6.16

Key Statistics

Open

$4.06

Day High

$4.15

Day Low

$3.90

Prev. Close

$4.05

VolumeShares traded today.

874.70K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$449.34M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.81

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$6.16

52W LowLowest price over the past 52 weeks.

$1.96

50D MAAverage closing price over the last 50 trading days.

$4.14

200D MAAverage closing price over the last 200 trading days.

$3.63

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+1.8%

1M

+0.3%

6M

+79.9%

YTD

+41.2%

1Y

+53.3%

About

Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.

www.perspectivetherapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNYSE MKT LLC
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CATX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.